Pronase treatment enhances the sensitivity of B cell flow cytometry crossmatch: A single-center data analysis
{{output}}
The Flow Cytometry Crossmatch (FCXM) is a vital tool in HLA laboratories for assessing transplantation immunological risk. This study evaluates FCXM results using data from 2018 to 2023, with the aim to assess the efficacy of pronase treatment in FCXM assay by... ...
